A detailed history of Hancock Whitney Corp transactions in Amgen Inc stock. As of the latest transaction made, Hancock Whitney Corp holds 44,323 shares of AMGN stock, worth $11.7 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
44,323
Previous 44,455 0.3%
Holding current value
$11.7 Million
Previous $13.9 Million 2.82%
% of portfolio
0.47%
Previous 0.48%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$309.38 - $337.38 $40,838 - $44,534
-132 Reduced 0.3%
44,323 $14.3 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $138,469 - $168,276
527 Added 1.2%
44,455 $13.9 Million
Q1 2024

May 16, 2024

BUY
$268.87 - $324.56 $1.49 Million - $1.79 Million
5,530 Added 14.4%
43,928 $12.5 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $335,989 - $379,036
-1,314 Reduced 3.31%
38,398 $11.1 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $135,781 - $168,576
621 Added 1.59%
39,712 $10.7 Million
Q2 2023

Nov 13, 2023

SELL
$214.27 - $253.37 $542,531 - $641,532
-2,532 Reduced 6.08%
39,091 $8.68 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $542,531 - $641,532
-2,532 Reduced 6.08%
39,091 $8.68 Million
Q1 2023

Nov 13, 2023

SELL
$225.79 - $275.2 $422,227 - $514,624
-1,870 Reduced 4.3%
41,623 $10.1 Million
Q1 2023

May 16, 2023

SELL
$225.79 - $275.2 $422,227 - $514,624
-1,870 Reduced 4.3%
41,623 $10.1 Million
Q4 2022

Nov 13, 2023

BUY
$229.03 - $291.01 $1.01 Million - $1.28 Million
4,402 Added 11.26%
43,493 $11.4 Million
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $6.43 Million - $8.17 Million
28,064 Added 181.89%
43,493 $11.4 Million
Q3 2022

Oct 26, 2022

BUY
$224.46 - $253.15 $1.4 Million - $1.58 Million
6,229 Added 67.71%
15,429 $3.48 Million
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $44,296 - $49,294
-192 Reduced 2.04%
9,200 $2.24 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $101,741 - $112,552
-464 Reduced 4.71%
9,392 $2.27 Million
Q4 2021

Jan 25, 2022

SELL
$198.88 - $227.6 $87,904 - $100,599
-442 Reduced 4.29%
9,856 $2.22 Million
Q3 2021

Nov 04, 2021

SELL
$212.27 - $248.7 $527,066 - $617,522
-2,483 Reduced 19.43%
10,298 $2.19 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $8.05 Million - $8.93 Million
-34,451 Reduced 72.94%
12,781 $3.12 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $602,707 - $702,357
-2,716 Reduced 5.44%
47,232 $11.8 Million
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $744,779 - $886,900
-3,442 Reduced 6.45%
49,948 $11.5 Million
Q3 2020

Nov 05, 2020

SELL
$234.65 - $260.95 $825,498 - $918,022
-3,518 Reduced 6.18%
53,390 $13.6 Million
Q2 2020

Jul 30, 2020

SELL
$197.81 - $242.74 $4.2 Million - $5.15 Million
-21,213 Reduced 27.15%
56,908 $13.4 Million
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $386,713 - $512,887
-2,122 Reduced 2.64%
78,121 $15.8 Million
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $320,521 - $411,980
-1,694 Reduced 2.07%
80,243 $19.3 Million
Q3 2019

Oct 29, 2019

SELL
$174.11 - $208.62 $769,217 - $921,683
-4,418 Reduced 5.12%
81,937 $15.9 Million
Q2 2019

Aug 29, 2019

SELL
$166.7 - $195.41 $549,109 - $643,680
-3,294 Reduced 3.67%
86,355 $15.9 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $852,621 - $961,090
4,714 Added 5.55%
89,649 $17 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $9.42 Million - $11 Million
52,788 Added 164.21%
84,935 $16.5 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $4.43 Million - $4.99 Million
23,904 Added 289.99%
32,147 $6.67 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $76,216 - $85,608
-459 Reduced 5.27%
8,243 $1.52 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $70,313 - $82,170
415 Added 5.01%
8,702 $1.48 Million
Q4 2017

Feb 12, 2018

SELL
$168.79 - $188.59 $24,812 - $27,722
-147 Reduced 1.74%
8,287 $1.44 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $111,749 - $127,588
-668 Reduced 7.34%
8,434 $1.57 Million
Q2 2017

Aug 11, 2017

BUY
N/A
9,102
9,102 $1.57 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.